About The Study: Prescribing for both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors in a type 1 diabetes (T1D) population identified in a database increased between 2010 and 2023. Differences in characteristics of the overall T1D population and those newly prescribed the medications are often associated with elevated cardiorenal risk profiles, suggesting...
Tag: <span>GLP-1</span>
Post
‘Gift That Keeps Giving’: The Impact of GLP-1 in Asthma
Akshay B. Jain, MD: Welcome back to Medscape at ADA 2024, where Dr James Kim, primary care physician from Calgary, Alberta, will be joining me, Akshay Jain, an endocrinologist from Vancouver, Canada, in deciphering the key highlights at the ADA conference and bringing our own clinical twist into what the relevance would be for people like...
Post
How Much Weight Can You Lose on a GLP-1 Drug? It Depends on These Factors
Ozempic Insulin injection pen for diabetics and weight lossCarolina Rudah / Getty ImagesHow much weight a person loses on liraglutide or semaglutide depends on a number of different factors, new research found.The study found that the type of medication a person takes, the treatment indication, the dosage, and other factors can have an impact on...
Post
A select few doctor groups are behind telehealth’s GLP-1 boom
Over the last two years, dozens of telehealth companies have started to offer the wildly popular GLP-1 drugs. A new STAT examination has found that just a handful of networks of doctors, nurse practitioners, and physician assistants are writing prescriptions for the slew of websites offering the weight loss drugs, including the compounded versions that...
Post
Study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection
September 20, 2024 by Cleveland Clinic Credit: Pixabay/CC0 Public DomainA Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals...
Post
Keeping your good mood while taking GLP-1s could take some intentionality, experts say
By Madeline Holcombe, CNN Updated 6:08 PM EDT, Thu September 19, 2024 Research has not shown a definitive connection between GLP-1s and mental health concerns. Jens Kalaene/picture alliance/Getty ImagesEditor’s note: If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing...
Post
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
By Meg Tirrell, CNNPublished 6:30 AM EDT, Tue September 17, 2024 The new crop of GLP-1 weight loss drugs all come in the form of injections. New pill versions are in trials now. Illustration by Leah Abucayan/CNNJared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually...
Post
Signal of Suicidality With GLP-1 RA Semaglutide, but Experts Urge Caution
Medscape Medical News Megan Brooks August 20, 2024 A new analysis has detected a signal of suicidal ideation associated with the glucagon-like peptide 1 receptor agonist (GLP-1 RA) semaglutide, especially among individuals concurrently using antidepressants or benzodiazepines. However, the investigators and outside experts urge caution in drawing any firm conclusions based on the study’s observations....
Post
Thyroid Warning on GLP-1s Could Raise Overdiagnosis Risk
Medscape Medical News > Conference News Kerry Dooley Young July 02, 2024 ORLANDO, Florida — Clinicians should keep in mind concerns about overdiagnosis of thyroid cancer when prescribing glucagon-like peptide 1 (GLP-1) drugs, as the US black box warning about this risk for this class of medicines for certain tumors in mice could trigger excess...
Post
Mounjaro, Zepbound: What Happens to Your Body When You Stop Taking Weight Loss Drugs
Mounjaro and Zepbound can help qualified individuals lose and maintain weight and blood glucose levels. These medicines are not recommended for short-term use. Stopping them can prompt weight regain, blood sugar spikes, and increased appetite, among other side effects. Like Ozempic and Wegovy, Mounjaro and Zepbound can help people control blood sugar levels and reduce...
- 1
- 2